CoreCap Advisors
IRON icon

CoreCap Advisors’s Disc Medicine IRON Stock Holding History

CoreCap Advisors’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-78
Closed -$5.7K – 3260
2026
Q2 		$5.7K Buy
+78
New +$5.36K ﹤0.01% 2253
2025
Q2 		– Sell
-9
Closed -$447 – 3001
2025
Q1 		$447 Sell
9
-19
-68% -$1.06K ﹤0.01% 2722
2024
Q4 		$1.78K Buy
+28
New +$1.62K ﹤0.01% 2262

Other funds holding IRON

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Pinnacle Associates
Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Versant Capital Management
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Root Financial Partners
Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

CoreCap Advisors's IRON Position: Q3 2026 in Review

CoreCap Advisors sold out of Disc Medicine (IRON) in Q3 2026, closing a stake of 78 shares — an estimated $5.7K sold.

CoreCap Advisors first reported a position in IRON in Q4 2024 and held it in 3 quarters. The position peaked at $5.7K in Q2 2026. 16 funds tracked by Wall St. Rank hold IRON as of Q3 2026.

  • CoreCap Advisors reported no remaining Disc Medicine position as of Q3 2026 after selling out during the quarter.
  • CoreCap Advisors sold 78 Disc Medicine shares in Q3 2026, an estimated $5.7K.
  • CoreCap Advisors first reported a position in Disc Medicine in Q4 2024 and held it in 3 quarters.
  • CoreCap Advisors's Disc Medicine position peaked at $5.7K in Q2 2026.
  • 16 funds tracked by Wall St. Rank held Disc Medicine as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.